Stanford discovery of gene fusion in ovarian cancer could lead to earlier diagnoses:

Stanford discovery of gene fusion in ovarian cancer could lead to earlier diagnoses: NCI Cancer Center News About 15 percent of cases of an aggressive, difficult-to-detect form of ovarian cancer contain a unique fusion between two neighboring, normally separate genes, say researchers at the Stanford University School of Medicine. Although gene fusions are known to occur … Continue reading “Stanford discovery of gene fusion in ovarian cancer could lead to earlier diagnoses:”

Stanford discovery of gene fusion in ovarian cancer could lead to earlier diagnoses: NCI Cancer Center News

About 15 percent of cases of an aggressive, difficult-to-detect form of ovarian cancer contain a unique fusion between two neighboring, normally separate genes, say researchers at the Stanford University School of Medicine. Although gene fusions are known to occur in prostate and some blood cancers, they have been notoriously difficult to identify in solid tumors. This is the first recurrent gene fusion found for ovarian cancer.

Click here to read full press release from Stanford University School of Medicine.

###

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply